@inbook{2d83a91550b64711ad073dd243dad49f,
title = "Central Nervous System Stimulants and Drugs That Suppress Appetite",
abstract = "The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. This is a review of the January 2015 to December 2015 publications on central nervous system stimulants and drugs that suppress appetite. It covers amphetamines (including lisdexamfetamine, methamphetamine and 3,4-methylenedioxymethamphetamine), methylphenidate, atomoxetine, modafinil and armodafinil, methylxanthines (caffeine), monotherapies and combinational therapies that suppress appetite (lorcaserin, phentermine, phentermine/topiramate) and medications used in Alzheimer's disease and cognitive decline (rivastigmine, donepezil and galantamine).",
keywords = "Adverse reactions, Alzheimer's disease, Amphetamines, Appetite suppressants, Armodafinil, Atomoxetine, Caffeine, Donepezil, Galantamine, Lisdexamfetamine, Lorcaserin, Methylphenidate, Methylxanthines, Modafinil, Phentermine, Qsymia, Rivastigmine, Treatment-emergent adverse effects",
author = "Zahner, {Matthew R.} and Bello, {Nicholas T.}",
note = "Publisher Copyright: {\textcopyright} 2016 Elsevier B.V.",
year = "2016",
doi = "10.1016/bs.seda.2016.07.007",
language = "English (US)",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "1--10",
booktitle = "Side Effects of Drugs Annual",
}